SA16B0CHUPH2
SA16B0CHUPH2
Specialized Medical Co.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 3.71B EUR | 4.19B EUR | 4.64B EUR | 4.51B EUR |
Enterprise Value | 4.47B EUR | 4.95B EUR | 5.35B EUR | 5.09B EUR |
Valuation Multiples | ||||
Trailing P/E | 13.49x | 15.07x | 17.22x | 19.06x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 2.36x | 2.66x | 2.99x | 3.86x |
Price to Book | 3.78x | 4.26x | 4.55x | 3.8x |
EV/Revenue | 2.84x | 3.15x | 3.45x | 4.35x |
EV/EBITDA | 14.55x | 11.54x | 12.74x | 14.51x |
Price to FCF (P/FCF) | 21.01x | 13.2x | 23.19x | 34.65x |
EV/FCF | 25.31x | 15.59x | 26.79x | 39.1x |
FCF Yield | 4.76% | 7.58% | 4.31% | 2.89% |